Drug Repackaging Company Recalls Tablets Due to Packaging Mix-Up

News
Article

Contract Packaging Resources issued a voluntary recall of naproxen sodium tablets because some cartons contain bottles of ibuprofen.

Contract Packaging Resources, a drug repackaging company, is voluntarily recalling 11,640 boxes of Assured brand naproxen sodium tablets because some cartons contain bottles of ibuprofen, a different pain reliever. The ibuprofen bottles were placed in the naproxen sodium boxes due to a packaging error. The affected products are: boxes of Assured brand naproxen sodium tablets 220 mg, 15 count (Lot #FH4102A) [SKU #122368/UPC #639277223685] containing bottles of ibuprofen softgels in 200-mg strength.

The recalled Assured-brand drug products were distributed nationwide to Dollar Tree and sold through Dollar Tree retail stores and website. Contract Packaging Resources is notifying its distributors and customers directly and arranging for replacement of all recalled products.

Source: FDA

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes